ChiCTR2400088145 版本V1.0 版本创建时间2024/08/12 17:59:35 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400088145 

最近更新日期:

Date of Last Refreshed on:

2024-08-12 17:59:12 

注册时间:

Date of Registration:

2024-08-12 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

针刺运动疗法对脑卒中后肩痛的疗效研究

Public title:

Clinical Observation on the Treatment of Post-stroke Hemiplegic Shoulder Pain with Acupuncture Motor Therapy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

针刺运动疗法对脑卒中后肩痛的疗效研究

Scientific title:

Clinical Observation on the Treatment of Post-stroke Hemiplegic Shoulder Pain with Acupuncture Motor Therapy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

周静 

研究负责人:

杨远滨 

Applicant:

Jing Zhou 

Study leader:

Yuanbin Yang 

申请注册联系人电话:

Applicant telephone:

+86 136 9354 1056

研究负责人电话:

Study leader's telephone:

+86 182 1089 7538

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

jymonica@aliyun.com

研究负责人电子邮件:

Study leader's E-mail:

duyiran0506@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市朝阳区中环南路6号望京医院

研究负责人通讯地址:

北京市朝阳区中环南路6号望京医院

Applicant address:

Wangjing Hospital of China Academy of Chinese Medical Sciences, 6 Zhonghuan South Road, Chaoyang District, Beijing

Study leader's address:

Wangjing Hospital of China Academy of Chinese Medical Sciences, 6 Zhonghuan South Road, Chaoyang District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国中医科学院望京医院

Applicant's institution:

Medical Ethics Committee of Wangjing Hospital of China Academy of Chinese Medical Sciences

研究负责人所在单位:

中国中医科学院望京医院

Affiliation of the Leader:

Medical Ethics Committee of Wangjing Hospital of China Academy of Chinese Medical Sciences

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

WJYY-XZKT-2024-007-P002

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国中医科学院望京医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Wangjing Hospital of China Academy of Chinese Medical Sciences

伦理委员会批准日期:

Date of approved by ethic committee:

2024-04-02 00:00:00

伦理委员会联系人:

王浩

Contact Name of the ethic committee:

Hao Wang

伦理委员会联系地址:

北京市朝阳区中环南路6号望京医院

Contact Address of the ethic committee:

Wangjing Hospital of China Academy of Chinese Medical Sciences, 6 Zhonghuan South Road, Chaoyang District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 8473 9681

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国中医科学院望京医院

Primary sponsor:

Medical Ethics Committee of Wangjing Hospital of China Academy of Chinese Medical Sciences

研究实施负责(组长)单位地址:

北京市朝阳区中环南路6号望京医院

Primary sponsor's address:

Wangjing Hospital of China Academy of Chinese Medical Sciences, 6 Zhonghuan South Road, Chaoyang District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

朝阳区

Country:

China

Province:

Beijing

City:

Chaoyang District

单位(医院):

中国中医科院望京医院

具体地址:

北京市朝阳区中环南路6号望京医院

Institution
hospital:

Wangjing Hospital of China Academy of Chinese Medical Sciences

Address:

Wangjing Hospital, China Academy of Chinese Medical Sciences, No. 6 Zhonghuan South Road, Chaoyang District, Beijing

经费或物资来源:

中国中医科院望京医院

Source(s) of funding:

Wangjing Hospital of China Academy of Chinese Medical Sciences

Target disease:

Post-stroke Hemiplegic Shoulder Pain

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

(1)通过观察针刺运动疗法缓解脑卒中后肩痛的临床疗效,建立一套治疗脑卒中后肩痛切实、有效、方便、安全的中医康复治疗方案,进一步临床推广应用,对中医康复的发展起到行业引领作用。 (2)建立针刺治疗前后fNIRS定量评估的评价指标与评价方法,初步探索疼痛改善下疼痛、情绪相关的脑网络变化。  

Objectives of Study:

1.By observing the clinical effect of acupuncture motor therapy on post-stroke hemiplegic shoulder pain patients, to establish a set of effective, convenient and safe rehabilitation treatment for post-stroke hemiplegic shoulder pain patients. And then to clinical application, the development of traditional Chinese medicine rehabilitation plays a leading role in the industry. 2.By establish the indexes and methods of fNIRS in acupuncture treatment, to explore the changes of brain network related to pain and emotion under pain improvement.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)参照中华医学会神经病学分会《中国各类主要脑血管病诊断要点2019》,符合脑出血或脑梗死的诊断标准; (2)年龄在30-70岁之间; (3)病程在脑卒中后2周-3个月之间,病情稳定,能够耐受针灸及康复等治疗; (4)患者出现由脑卒中引起的肩痛; (5)卒中前无肩痛相关病史; (6)自愿参与本临床试验,并签署知情同意书的患者。

Inclusion criteria

1. According to the diagnostic essentials of major cerebrovascular diseases in China 2019 published by Neurology Branch of Chinese Medical Association, the diagnostic criteria of cerebral hemorrhage or cerebral infarction were met. 2. Aged between 30 and 70. 3.The course of disease ranged from 2 weeks to 3 months after stroke, condition is stable and able to tolerate acupuncture and rehabilitation. 4. The patient with shoulder pain due to stroke. 5. There was no history of shoulder pain before stroke. 6. Patients who volunteered to participate in the clinical trial and signed an informed consent form.

排除标准:

(1)脑外伤、脑肿瘤及颅脑术后等非脑血管病变原因者; (2)经检查有严重肩袖损伤患者; (3)严重失语症、严重听理解和认知功能障碍不能配合治疗的患者; (4)以前有过卒中发作史和/或遗留有肢体功能障碍的患者; (5)依从性差,不按医嘱进行治疗者; (6)既往进行过系统康复治疗者; (7)既往服用过止痛药物者。

Exclusion criteria:

1. Brain trauma, brain tumor and post-cranio-cerebral operation were not the causes of cerebrovascular diseases. 2. The patients with severe rotator cuff injury. 3. Severe aphasia, severe hearing comprehension and cognitive impairment can not cooperate with the treatment of patients. 4.Patients with a previous history of stroke and/or residual limb dysfunction. 5.The patients with poor compliance did not follow the Doctor's advice. 6.Those who had undergone systematic rehabilitation therapy before. 7.Those who has taken pain medication in the past.

研究实施时间:

Study execute time:

From 2023-11-27 00:00:00 To 2025-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-08-19 00:00:00 To 2025-11-30 00:00:00  

干预措施:

Interventions:

组别:

研究组

样本量:

54

Group:

Treatment group

Sample size:

干预措施:

常规康复治疗及针刺运动疗法

干预措施代码:

Intervention:

Rehabilitation therapy and Acupuncture Motor Therapy

Intervention code:

组别:

对照组

样本量:

54

Group:

Control group

Sample size:

干预措施:

常规康复治疗

干预措施代码:

Intervention:

Rehabilitation therapy

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

朝阳区 

Country:

China 

Province:

Beijing 

City:

Chaoyang District 

单位(医院):

中国中医科学院望京医院 

单位级别:

三级甲等医院 

Institution
hospital:

Wangjing Hospital of China Academy of Chinese Medical Sciences

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

视觉模拟评分法

指标类型:

主要指标

Outcome:

visual analogue scale,VAS

Type:

Primary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

Scale

指标中文名:

Constant-Murley肩关节功能评价量表

指标类型:

次要指标

Outcome:

Constant-Murley shoulder joint function assessment scale, CMS

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

Scale

指标中文名:

肩关节活动度

指标类型:

次要指标

Outcome:

range of motion,ROM

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

Scale

指标中文名:

近红外脑功能成像测试

指标类型:

次要指标

Outcome:

functional near-infrared spectroscopy, fNIRS

Type:

Secondary indicator

测量时间点:

测量方法:

近红外脑功能成像仪

Measure time point of outcome:

Measure method:

functional near-infrared spectroscopy

指标中文名:

汉密尔顿抑郁量表

指标类型:

次要指标

Outcome:

Hamilton depression scale,HAMD

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

Scale

指标中文名:

上肢Fugl-Meyer运动功能评定

指标类型:

次要指标

Outcome:

Upper Limb Fugl-Meyer Assessment, FMA-UE

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

Scale

指标中文名:

汉密尔顿焦虑量表

指标类型:

次要指标

Outcome:

Hamilton Anxiety Scale,HAMA

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

Scale

指标中文名:

匹兹堡睡眠量表

指标类型:

次要指标

Outcome:

pittsburghsleepqualityindex,PSQI

Type:

Secondary indicator

测量时间点:

测量方法:

量表

Measure time point of outcome:

Measure method:

Scale

指标中文名:

肩关节超声

指标类型:

次要指标

Outcome:

Ultrasound of shoulder joint

Type:

Secondary indicator

测量时间点:

测量方法:

超声仪测量

Measure time point of outcome:

Measure method:

Ultrasound

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 30 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表:先将108例患者从1编号到108,然后从随机数字表中任一行任一列开始,以此读取3位数做为一个随机数录入编号下面,再将全部选出的随机数从小到大进行编序号,记录在第三行。规定1-54为对照组,55-108为研究组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Table of random numbers: The 108 patients were numbered from 1 to 108, then start with any row or column in the random number table, read the 3-DIGIT number as a random number below the input number. All the selected random numbers are numbered from small to large, is recorded on the third line. 1-54 was the control group, 55-108 is the research group.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

因课题特殊性,所采用的干预方式为针刺运动疗法,因此采用单盲法,盲评估者和统计分析者。

Blinding:

Due to the specificity of the subject, the intervention methods used is acupuncture motor therapy, so the single-blind method, blind evaluator and statistical analyst are used.

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not publicly

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

填写CRF表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Fill in the

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-08-12 17:59:12